Localized Radiation Therapy is highly popular as Post-Operative Treatment for Oligodendroglioma


Published on : Dec 12, 2019

Oligodendroglioma is a type of glioma that generally occurs in the frontal lobe of brain. Oligodendroglioma cases have increased owing to the improvement in its recognition and diagnosis. Advancements in imaging techniques such as magnetic resonance imaging have improved the diagnosis of gliomas. Major symptoms include seizures, headaches, mental status change, visual complaints, localized weakness, vertigo and nausea.

An intelligence report titled, “Oligodendroglioma-Pipeline Review, H2 2019” is the source of all the stated insights. This report is the latest addition to Market Research Hub’s ever growing repository.

Methods including CT scan and MRI are employed to identify the affected location and determine the configuration of tumor. Identification of location is important as Oligodendroglioma has the tendency to occur at unexpected locations. Oligodendroglioma is known to be inter-cranial tumor which generally develops calcification. Positron emission tomography provides different medical details of Oligodendroglioma patient that include glucose metabolism, amino acid metabolism and blood flow. Fluorine-18 ?uorodeoxy-glucose is used as a diagnostic tool that distinguishes between scar, necrosis and gliotic tissue in growing glial tumor. Carbon-11-methionine (11C-MET) PET holds the potential to differentiate between Oligodendroglioma and low-grade astrocytoma.

Surgery is primary treatment

Surgical treatment is the leading treatment method. Tumors generally re-occur after surgery and its rate is low in patients with low-grade tumor. Localized radiation therapy is provided to these patients after surgery. PVC chemotherapy is administered to various patients. Its side-effects have surfaced lately and a new alkylating agent is being used as its replacement. It is expected to exhibit greater convenience and tolerance than other types of chemotherapy. Majority of Oligodendroglioma patients receive chemotherapy along with radiation therapy.

Reirradiation is presumed to be viable treatment option for patients suffering from recurring gliomas. Carboplatin is used in treatment of recurrent Oligodendroglioma. Oligodendrogliomas that are progressive or recurrent demand additional clinical trials to determine the required treatment.

Oligodendroglioma pipeline review H2 2019: Report Synopsis

Quantitative and qualitative assessment exhort intelligence and overarching report on the Oligodendroglioma pipeline review H2 2019. Further, the report thoroughly delineates various aspects of the market that will potentially have considerable influence on the development of the Oligodendroglioma pipeline review H2 2019. As such, those aspects incorporate drivers, trends, restraints, and opportunities. Furthermore, the report elucidates segregation of the market that provides an exhaustive analysis on Oligodendroglioma.

An insightful and deep-dive assessment of the competitive assessment of the Oligodendroglioma pipeline review H2 2019 pins hope on Porters’ Five Force Analysis. Accordingly, the Porters’ Five Force Analysis offers a pressing analysis on the potential strategies of the preeminent players in the Oligodendroglioma pipeline review H2 2019. In addition, the business strategies counts on company overview, product portfolio, SWOT analysis, key differentiation and recent development.

Oligodendroglioma pipeline review H2 2019: Research Methodology

Primary sources and secondary sources propel intelligence report on Oligodendroglioma pipeline review H2 2019 that provide deep dive analysis on the market. As such, the report provides reliable and unbiased projections, and assessments which have palpable impact on the market size and historical data. Besides, the report also counts on primary sources which hinges upon in-depth and intelligent analysis from well-grounded and reliable experts, telephonic interview, and a thorough assessment from surveys and seasoned analyst.

Request a Sample with TOC in a PDF format: https://www.marketresearchhub.com/enquiry.php?type=S&repid=2578957

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision-makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top